Methylene blue for use in therapy of hepatitis b and/or hepatitis d infection
OwnerAndreas CERNY, Thomas CERNY +2inventors
InventorsAndreas CERNY, Thomas CERNY, Sophie CLÉMENT-LEBOUBE, Francesco NEGRO
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of methylene blue in the treatment of treatment of hepatitis B (HBV) and/or hepatitis D (HDV) infection of a human patient as well as pharmaceutical compositions applicable in this treatment.
Claims20
A methylene blue (MB) compound for use in the therapeutic or prophylactic treatment, in particular in the therapeutic treatment, of hepatitis B (HBV) and/or hepatitis D (HDV) infection of a human patient.
The use, compositions or method of anyone of the preceding claims, wherein MB or a pharmaceutically acceptable salt or hydrate thereof is applied.
The use or method of anyone of the preceding claims, wherein MB treatment is applied in combination with active or passive immunization, any type of antiviral antibody or any type of antiviral compound effective against HBV and/or HDV.
Dependencies are inferred from the claim text.